A Double-Blind, Placebo-Controlled Crossover Study of Repeat Rivastigmine (Exelon®) Administration in Young Healthy Male Volunteers - Related Studies

Home Search Study Topics Glossary

A Double-Blind, Placebo-Controlled Crossover Study of Repeat Rivastigmine (Exelon®) Administration in Young Healthy Male Volunteers (RIVA-1)

This study is not yet open for participant recruitment.

Study NCT00624663 Information provided by Tel-Aviv Sourasky Medical Center

First Received: October 30, 2007 Last Updated: February 15, 2008 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Interventions listed in this trial

Rivastigmine

More general drug interventions related to this trial

Sponsors listed in this trial